Literature DB >> 33507972

Synergistic effect and ultrastructural changes in Trypanosoma cruzi caused by isoobtusilactone A in short exposure of time.

Júlio Menta de Almeida1, Felipe Oliveira Nunes2, Lígia Fernanda Ceole3, Tabata D'Maiella Freitas Klimeck3, Letícia Alves da Cruz1, Danilo Tófoli2, Beatriz Santana Borges3, Walmir Silva Garcez2, Inês Aparecida Tozetti1, Lia Carolina Soares Medeiros3, Fernanda Rodrigues Garcez2, Alda Maria Teixeira Ferreira1.   

Abstract

Butanolides have shown a variety of biological effects including anti-inflammatory, antibacterial, and antiprotozoal effects against certain strains of Trypanosoma cruzi. Considering the lack of an effective drug to treat T. cruzi infections and the prominent results obtained in literature with this class of lactones, we investigated the anti-T. cruzi activity of five butanolides isolated from two species of Lauraceae, Aiouea trinervis and Mezilaurus crassiramea. Initially, the activity of these compounds was evaluated on epimastigote forms of the parasite, after a treatment period of 4 h, followed by testing on amastigotes, trypomastigotes, and mammalian cells. Next, the synergistic effect of active butanolides against amastigotes was evaluated. Further, metacyclogenesis inhibition and infectivity assays were performed for the most active compound, followed by ultrastructural analysis of the treated amastigotes and trypomastigotes. Among the five butanolides studied, majoranolide and isoobtusilactone A were active against all forms of the parasite, with good selectivity indexes in Vero cells. Both butanolides were more active than the control drug against trypomastigote and epimastigote forms and also had a synergic effect on amastigotes. The most active compound, isoobtusilactone A, which showed activity against all tested strains inhibited metacyclogenesis and infection of new host cells. In addition, ultrastructural analysis revealed that this butanolide caused extensive damage to the mitochondria of both amastigotes and trypomastigotes, resulting in severe morphological changes in the infective forms of the parasite. Altogether, our results highlight the potential of butanolides against the etiologic agent of Chagas disease and the relevance of isoobtusilactone A as a strong anti-T. cruzi drug, affecting different events of the life cycle and all evolutionary forms of parasite after a short period of exposure.

Entities:  

Year:  2021        PMID: 33507972      PMCID: PMC7842926          DOI: 10.1371/journal.pone.0245882

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  70 in total

1.  In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.

Authors:  Julián Ernesto Nicolás Gulin; Mackenzie Anne Eagleson; Rodrigo A López-Muñoz; María Elisa Solana; Jaime Altcheh; Facundo García-Bournissen
Journal:  Acta Trop       Date:  2020-06-27       Impact factor: 3.112

2.  Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).

Authors:  Valeria P Sülsen; Fernanda M Frank; Silvia I Cazorla; Claudia A Anesini; Emilio L Malchiodi; Blanca Freixa; Roser Vila; Liliana V Muschietti; Virginia S Martino
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 3.  Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America.

Authors:  Julio Alonso-Padilla; Nuria Cortés-Serra; María Jesús Pinazo; María Elena Bottazzi; Marcelo Abril; Fabiana Barreira; Sergio Sosa-Estani; Peter Jay Hotez; Joaquim Gascón
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-13       Impact factor: 5.091

4.  Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi.

Authors:  Paulo André Teixeira de Moraes Gomes; Arsênio Rodrigues Oliveira; Marcos Veríssimo de Oliveira Cardoso; Edna de Farias Santiago; Miria de Oliveira Barbosa; Lucianna Rabelo Pessoa de Siqueira; Diogo Rodrigo Magalhães Moreira; Tanira Matutino Bastos; Fábio André Brayner; Milena Botelho Pereira Soares; Andresa Pereira de Oliveira Mendes; Maria Carolina Accioly Brelaz de Castro; Valéria Rego Alves Pereira; Ana Cristina Lima Leite
Journal:  Eur J Med Chem       Date:  2016-01-11       Impact factor: 6.514

Review 5.  Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.

Authors:  Vilma G Duschak
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2016

6.  Trypanocidal activity of guaianolide obtained from Tanacetum parthenium (L.) Schultz-Bip. and its combinational effect with benznidazole.

Authors:  Juliana Cogo; Angelo de Oliveira Caleare; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Izabel Cristina Piloto Ferreira; Celso Vataru Nakamura
Journal:  Phytomedicine       Date:  2012-10-13       Impact factor: 5.340

Review 7.  Evaluation and treatment of chagas disease in the United States: a systematic review.

Authors:  Caryn Bern; Susan P Montgomery; Barbara L Herwaldt; Anis Rassi; Jose Antonio Marin-Neto; Roberto O Dantas; James H Maguire; Harry Acquatella; Carlos Morillo; Louis V Kirchhoff; Robert H Gilman; Pedro A Reyes; Roberto Salvatella; Anne C Moore
Journal:  JAMA       Date:  2007-11-14       Impact factor: 56.272

8.  Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.

Authors:  D E Perez-Mazliah; M G Alvarez; G Cooley; B E Lococo; G Bertocchi; M Petti; M C Albareda; A H Armenti; R L Tarleton; S A Laucella; R Viotti
Journal:  J Antimicrob Chemother       Date:  2012-10-26       Impact factor: 5.790

9.  Butenolides from Nectandra oppositifolia (Lauraceae) displayed anti-Trypanosoma cruzi activity via deregulation of mitochondria.

Authors:  Geanne A Alves Conserva; Thais A da Costa-Silva; Maiara Amaral; Guilherme M Antar; Bruno J Neves; Carolina H Andrade; Andre G Tempone; João Henrique G Lago
Journal:  Phytomedicine       Date:  2018-10-09       Impact factor: 5.340

10.  Mode of Action of the Sesquiterpene Lactones Psilostachyin and Psilostachyin C on Trypanosoma cruzi.

Authors:  Valeria P Sülsen; Vanesa Puente; Daniela Papademetrio; Alcira Batlle; Virginia S Martino; Fernanda M Frank; María E Lombardo
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more
  2 in total

1.  Trypanin Disruption Affects the Motility and Infectivity of the Protozoan Trypanosoma cruzi.

Authors:  Jose L Saenz-Garcia; Beatriz S Borges; Normanda Souza-Melo; Luiz V Machado; Juliana S Miranda; Lisandro Alfonso Pacheco-Lugo; Nilmar S Moretti; Richard Wheleer; Lia C Soares Medeiros; Wanderson D DaRocha
Journal:  Front Cell Infect Microbiol       Date:  2022-01-07       Impact factor: 5.293

2.  Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study.

Authors:  Carlos J Bethencourt-Estrella; Samuel Delgado-Hernández; Atteneri López-Arencibia; Desirée San Nicolás-Hernández; Ines Sifaoui; David Tejedor; Fernando García-Tellado; Jacob Lorenzo-Morales; José E Piñero
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.